Companies / Aprea Therapeutics, Inc. / Activity
Activity — Aprea Therapeutics, Inc.
8 moves.
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | AIGH Capital Management LLC 13F manager | Add | Common Stock | $517.5K | +645K +174.07% | 1,015,541 8.07% of shares | low |
| Q1 2026 as of | Geode Capital Management, LLC 13F manager | Add | Common Stock | $59.6K | +78K +190.92% | 119,131 0.95% of shares | low |
| Q1 2026 as of | Renaissance Technologies LLC 13F manager | New | Common Stock | $19.1K | +25K | 25,100 0.20% of shares | low |
| Q1 2026 as of | BNP Paribas Financial Markets 13F manager | Add | Common Stock | $9.5K | +12K +45.68% | 39,817 0.32% of shares | low |
| Q2 2026 as of | Persistent Asset Partners Ltd 13F manager | New | Common Stock | $9.2K | +11K | 11,490 0.09% of shares | low |
| Q2 2026 as of | LPL Financial LLC 13F manager | Trim | Common Stock | $-8.0K | -10K -38.38% | 16,052 0.13% of shares | low |
| Q4 2025 as of | Bank of America Corp /De 13F manager | Trim | Common Stock | $-1.3K | -2K -32.13% | 3,299 0.03% of shares | low |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Trim | Common Stock | $-1.1K | -1K -15.65% | 7,173 0.06% of shares | low |